Archive | October, 2017

Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain

In continuation of my update on Zilretta  Flexion Therapeutics, Inc. announced,  that  Food and Drug Administration (FDA) approved Zilretta (triamcinolone acetonide extended-release injectable suspension), the first and only extended-release, intra-articular injection for osteoarthritis knee pain. Zilretta is a non-opioid medicine that employs Flexion’s proprietary microsphere technology to provide proven pain relief over 12 weeks. “The approval […]

Continue Reading

FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions

In continuation of my update on Pregabalin Pfizer Inc.  announced today that the  Food and Drug Administration (FDA) has approved Lyrica CR (pregabalin) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic peripheral neuropathy (pDPN) and the management of postherpetic neuralgia (PHN). Lyrica CR did not receive approval for the management of fibromyalgia. “Lyrica CR was developed […]

Continue Reading

Drug Patent Expirations for Oct 12, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. EFFIENT (prasugrel hydrochloride) Eli Lilly And Co Patent number: 5,288,726 Expiration Date: Oct 14, 2017 BYETTA (exenatide synthetic) Astrazeneca Ab Patent number: 7,297,761 Expiration Date: Oct […]

Continue Reading

Discussing Biotechnology Commercialization at UT Arlington

I will be giving a pair of talks on biotechnology commercialization at the University of Texas at Arlington on November 2nd and 3rd (for more on my speaking engagements see https://www.thinkbiotech.com/ ). If you are in the area and would like more information, please contact me. To arrange for a talk on global biotechnology (based on my […]

Continue Reading

Drug Patent Expirations for Oct 5, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AGGRASTAT (tirofiban hydrochloride) Medicure Patent number: 5,978,698 Expiration Date: Oct 8, 2017 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information try […]

Continue Reading